Monoamine oxidase b inhibitors

Intervention

1 paper1 finding

  • 1 lab in 1 country
  • Funder: Jeju National University Hospital
  • Humans1

Outcomes

1

Restricted mean survival time

upin humans1

1 study
  1. Monoamine oxidase b inhibitors increase restricted mean survival time in humans (ΔRMST = 3.45 months, 95% CI 1.92-4.98).

    Humanscompared with levodopa monotherapy in newly diagnosed Parkinson's disease5-yearn = 4,949

    Association of early adjunctive dopaminergic therapy and 5-year mortality in Parkinson's disease: A nationwide cohort study

    Parkinsonism & related disorders17 Aug 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01 in 12 months